Phase II trial of infusional cyclophosphamide, idarubicin, and etoposide in poor prognosis non-Hodgkin's lymphoma

  • Huda Salman
  • , Alejandra Perez
  • , Joseph A. Sparano
  • , Howard Ratech
  • , Abdissa Negassa
  • , Una Hopkins
  • , Gina Villani
  • , Joachim Fuks
  • , Peter H. Wiernik

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of infusional cyclophosphamide, idarubicin, and etoposide in poor prognosis non-Hodgkin's lymphoma'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science